Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
- 31 July 2020
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 884, 173455
- https://doi.org/10.1016/j.ejphar.2020.173455
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus EntryJournal of Virology, 2012
- Evidence for a Common Evolutionary Origin of Coronavirus Spike Protein Receptor-Binding SubunitsJournal of Virology, 2012
- The ANG-(1–7)/ACE2/mas axis in the regulation of nephron functionAmerican Journal of Physiology-Renal Physiology, 2010
- Androgen receptor and androgen-dependent gene expression in lungMolecular and Cellular Endocrinology, 2010
- Association of Hydrophilic Versus Lipophilic Angiotensin-Converting Enzyme Inhibitor Use on Pneumonia-Related MortalityThe American Journal of the Medical Sciences, 2008
- The androgen‐regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinomaThe Journal of Pathology, 2008
- ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1–7)Kidney International, 2006
- Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1–7) expression in the aorta of spontaneously hypertensive ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with ReceptorJournal of Virology, 2004
- A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2Online Journal of Public Health Informatics, 2004